Multiple sclerosis presented as clinically isolated syndrome: The need for early diagnosis and treatment

Therapeutics and Clinical Risk Management

Volumn 4, Issue 3, 2008, Pages 627-630

  Pelidou, Sigliti Henrietta ^a   Giannopoulos, Sotorios ^a   Tzavidi, Sotiria ^a   Lagos, Georgios ^a   Kyritsis, Athanassios P ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Clinically isolated syndrome; Multiple sclerosis; Optic neuritis; Transverse myelitis

Indexed keywords

IMMUNOMODULATING AGENT;

ADOLESCENT; ADULT; ARTICLE; BLOOD ANALYSIS; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; EVOKED RESPONSE; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; MYELITIS; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPHTHALMOPLEGIA; OPTIC NEURITIS; TONIC CLONIC SEIZURE;

EID: 47849129695     PISSN: 11766336     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Bhatti MT, Schmitt NJ, Beatty RL. 2005. Acute inflammatory demyelinating optic neuritis: current concepts in diagnosis and management. Optometry, 76:526-35.
2. Brettschneider J, Petzold A, Junker A, et al. 2006. Axonal damage markers in the cerebrospinal fluid of patients with clinically isolated syndrome improve predicting conversion to definite multiple sclerosis. Mult Scler, 12:143-8.
3. Dalton CM, Brex PA, Miszkiel KA, et al. 2002. Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis. Ann Neurol, 52:47-53.
4. Delalande S, deSeze S, Fauchais AL, et al. 2004. Neurologic manifestations in primary Sjogren syndrome: a study of 82 patients. Medicine, 83:280-91.
5. Ferreira S, D'Cruz DP, Hughes GR. 2005. Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: where do we stand? Rheumatology, 44:434-42.
6. Ghezzi A, Martinelli V, Tom V, et al. 1999. Long-term follow-up of isolated optic neuritis: the risk of developing multiple sclerosis, its outcome, and the prognostic role of paraclinical tests. J Neurol, 246:770-75.
7. Hickman SJ, Dalton CM, Miller DH, et al. 2002. Management of acute optic neuritis. Lancet, 360:1953-62.
8. Kieseier BC, Hemmer B, Hartung HP. 2005. Multiple sclerosis-novel insights and new therapeutic strategies. Curr Opin Neurol, 18:211-20.
9. Lim ET, Berger T, Reindl M, et al. 2005. Anti-myelin antibodies do not allow earlier diagnosis of multiple sclerosis. Mult Scler, 11:492-4.
10. Lin X, Tench CR, Evangelou N, et al. 2004. Measurement of spinal cord atrophy in multiple sclerosis. J Neuroimaging, 14(Suppl 3):20S-26S.
11. Masjuan J, Alvarez-Cermeno JC, Garcia-Barragan N, et al. 2006. Clinically isolated syndromes: a new oligoclonal band test accurately predicts conversion to MS. Neurology, 66:576-8.
12. McDonald WI, Compston A, Edan G, et al. 2001. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol, 50:121-7.
13. Miller D, Barkhof F, Montalban X, et al. 2005. Clinically isolated syndromes suggestive of multiple sclerosis, part 2: non-conventional MRI, recovery processes, and management. Lancet Neurol, 4:341-8.
14. Miller DH, Ormerod IE, Rudge P, et al. 1989. The early risk of multiple sclerosis following isolated acute syndromes of the brain stem and spinal cord. Ann Neurol, 26:635-9.
15. [ONSG] Optic Neuritis Study Group. 1991. The clinical profile of optic neuritis: experience of the optic neuritis treatment trial. Arch Ophthalmol, 109:1673-78.
16. [ONSG] Optic Neuritis Study Group. 1997. The 5-year risk of MS after optic neuritis: experience of the optic neuritis treatment trial. Neurology, 49:1404-13.
17. Paolillo A, Piattella MC, Pantano P, et al. 2004. The relationship between inflammation and atrophy in clinically isolated syndromes suggestive of multiple sclerosis: a monthly MRI study after triple-dose gadolinium-DTPA. J Neurol, 251:432-9.
18. Pestalozza IF, Pozzilli C, Di Legge S, et al. 2005. Monthly brain magnetic resonance imaging scans in patients with clinically isolated syndrome. Mult Scler, 11:390-4.
19. Polman CH, Reingold SC, Edan G, et al. 2005. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol, 58:840-6.
20. Poser CM, Brinar VV. 2001. Diagnostic criteria for multiple sclerosis. Clin Neurol Neurosurg, 103:1-11.
21. Qin Y, Duquette P, Zhang Y, et al. 2003. Intrathecal B-cell clonal expansion, an early sign of humoral immunity, in the cerebrospinal fluid of patients with clinically isolated syndrome suggestive of multiple sclerosis. Lab Invest, 83:1081-8.
22. Reske D, Petereit HF, Heiss WD. 2005. Difficulties in the differentiation of chronic inflammatory diseases of the central nervous system - value of cerebrospinal fluid analysis and immunological abnormalities in the diagnosis. Acta Neurol Scand, 112:207-13.
23. Rot U, Mesec A. 2006. Clinical, MRI, CSF and electrophysiological findings in different stages of multiple sclerosis. Clin Neurol Neurosurg, 108:271-4.
24. Sastre-Garriga J, Tintore M, Rovira A, et al. 2003. Conversion to multiple sclerosis after a clinically isolated syndrome of the brainstem: cranial magnetic resonance imaging, cerebrospinal fluid and neurophysiological findings. Mult Scler, 9:39-43.
25. Speciale L, Saresella M, Caputo D, et al. 2000. Serum auto antibodies presence in multiple sclerosis patients treated with beta-interferon 1a and 1b. J Neurovirol, 6(Suppl 2):S57-61.
26. Tan EM, Cohen AS, Fries JF, et al. 1982. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum, 25:1271-7.
27. Theodoridou A, Settas L. 2006. Demyelination in rheumatic diseases. J Neurol Neurosurg Psychiatry, 77:290-5.
28. [TMC] Transverse Myelitis Consortium Working Group. 2002. Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology, 59:499-505.
29. Vitali C, Bombardieri S, Jonsson R, et al. 2002. European Study Group on Classification Criteria for Sjogrens Syndrome Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis, 61:554-8.
30. Wilson WA, Gharavi AE, Koike T, et al. 1999. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum, 42:1309-11.